Panou T, Gouveri E, Popovic D, Papazoglou D, Papanas N
    
    
    Diabetes Ther. 2025; 16(3):371-411.
  
  
    PMID: 39928224
    
          PMC: 11868477.
    
          DOI: 10.1007/s13300-025-01699-7.
      
 
                                  
  
    Wang X, Abu Bakar M, Kassim M, Shariff K, Mohamad Rosdi M
    
    
    Biochem Biophys Rep. 2025; 41:101928.
  
  
    PMID: 39926209
    
          PMC: 11803244.
    
          DOI: 10.1016/j.bbrep.2025.101928.
      
 
                                  
  
    Lin Z, Gao H, Shi S, Li Y
    
    
    World J Diabetes. 2025; 16(1):92711.
  
  
    PMID: 39817219
    
          PMC: 11718448.
    
          DOI: 10.4239/wjd.v16.i1.92711.
      
 
                                  
  
    Kojima K, Nakamura N, Hayashi A, Kondo S, Miyabe M, Kikuchi T
    
    
    Int J Mol Sci. 2024; 25(20).
  
  
    PMID: 39456763
    
          PMC: 11507260.
    
          DOI: 10.3390/ijms252010979.
      
 
                                  
  
    Wang R, Qu J, Chen M, Han T, Liu Z, Wang H
    
    
    Int Urol Nephrol. 2024; 57(2):643-653.
  
  
    PMID: 39382603
    
    
          DOI: 10.1007/s11255-024-04214-2.
      
 
                              
              
                              
                                      
  The Traditional Chinese Medicine in Treating Diabetic Nephropathy: A Bibliometric Analysis.
  
    Sun J, Shen J, Liu L, Du J
    
    
    J Multidiscip Healthc. 2024; 17:4627-4636.
  
  
    PMID: 39381421
    
          PMC: 11460354.
    
          DOI: 10.2147/JMDH.S482473.
      
 
                                          
                                                          
  MSU crystallization promotes fibroblast proliferation and renal fibrosis in diabetic nephropathy via the ROS/SHP2/TGFβ pathway.
  
    Li J, Zhang J, Zhao X, Tian L
    
    
    Sci Rep. 2024; 14(1):20251.
  
  
    PMID: 39215017
    
          PMC: 11364842.
    
          DOI: 10.1038/s41598-024-67324-y.
      
 
                                          
                                                          
  The immune-inflammation factor is associated with diabetic nephropathy: evidence from NHANES 2013-2018 and GEO database.
  
    Wang Y, Zhao S, Wang Y, Xu J, Wang J
    
    
    Sci Rep. 2024; 14(1):17760.
  
  
    PMID: 39085362
    
          PMC: 11291652.
    
          DOI: 10.1038/s41598-024-68347-1.
      
 
                                          
                                                          
  Targeting ferroptosis: a new therapeutic opportunity for kidney diseases.
  
    Long Z, Luo Y, Yu M, Wang X, Zeng L, Yang K
    
    
    Front Immunol. 2024; 15:1435139.
  
  
    PMID: 39021564
    
          PMC: 11251909.
    
          DOI: 10.3389/fimmu.2024.1435139.
      
 
                                          
                                                          
  Evaluating new biomarkers for diabetic nephropathy: Role of α2-macroglobulin, podocalyxin, α-L-fucosidase, retinol-binding protein-4, and cystatin C.
  
    Li J, Sa R, Zhang Y, Yan Z
    
    
    World J Diabetes. 2024; 15(6):1212-1225.
  
  
    PMID: 38983807
    
          PMC: 11229980.
    
          DOI: 10.4239/wjd.v15.i6.1212.
      
 
                                          
                                                          
  Unveiling diabetic nephropathy: a novel diagnostic model through single-cell sequencing and co-expression analysis.
  
    Wang G, Zhao J, Zhou M, Lu H, Mao F
    
    
    Aging (Albany NY). 2024; 16(13):10972-10984.
  
  
    PMID: 38968594
    
          PMC: 11272118.
    
          DOI: 10.18632/aging.205982.
      
 
                                          
                                                          
  Ginsenoside Rg3 induces mesangial cells proliferation and attenuates apoptosis by miR-216a-5p/MAPK pathway in diabetic kidney disease.
  
    Chen Y, Peng Y, Li P, Jiang Y, Song D
    
    
    Aging (Albany NY). 2024; 16(11):9933-9943.
  
  
    PMID: 38850526
    
          PMC: 11210261.
    
          DOI: 10.18632/aging.205907.
      
 
                                          
                                                          
  Early onset stage III diabetic nephropathy in a child with Prader-Willi syndrome treated with dulaglutide: a case report.
  
    He Y, Xu R, Ma X, Zhou J, Qiu L
    
    
    Transl Pediatr. 2024; 13(5):833-839.
  
  
    PMID: 38840685
    
          PMC: 11148744.
    
          DOI: 10.21037/tp-23-518.
      
 
                                          
                                                          
  SRS 16-86 promotes diabetic nephropathy recovery by regulating ferroptosis.
  
    Qiao Y, Sun C, Kan S, He L, Wang Y, Gao H
    
    
    Exp Physiol. 2024; 109(7):1199-1210.
  
  
    PMID: 38812118
    
          PMC: 11215488.
    
          DOI: 10.1113/EP091520.
      
 
                                          
                                                          
  Sirt7/HIC1 complex participates in hyperglycaemia-mediated EndMT via modulation of SDC1 expression in diabetic kidney disease and metabolic memory.
  
    Lu L, Zhu M, Wu Q, Sun Z, Chen X, Miao C
    
    
    J Cell Mol Med. 2024; 28(9):e18336.
  
  
    PMID: 38686489
    
          PMC: 11058670.
    
          DOI: 10.1111/jcmm.18336.
      
 
                                          
                                                          
  Individuals Diagnosed With Type 2 Diabetes Mellitus and the Status of Vitamin B12 Deficiency: A Review.
  
    Batulwar P, Anjankar A
    
    
    Cureus. 2024; 16(2):e55103.
  
  
    PMID: 38558585
    
          PMC: 10978817.
    
          DOI: 10.7759/cureus.55103.
      
 
                                          
                                                          
  Jian-Pi-Gu-Shen-Hua-Yu Decoction Alleviated Diabetic Nephropathy in Mice through Reducing Ferroptosis.
  
    Lv S, Fan L, Chen X, Su X, Dong L, Wang Q
    
    
    J Diabetes Res. 2024; 2024:9990304.
  
  
    PMID: 38523631
    
          PMC: 10960652.
    
          DOI: 10.1155/2024/9990304.
      
 
                                          
                                                          
  Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
  
    Zhang X, Zhang J, Ren Y, Sun R, Zhai X
    
    
    Front Endocrinol (Lausanne). 2024; 15:1368481.
  
  
    PMID: 38455648
    
          PMC: 10918691.
    
          DOI: 10.3389/fendo.2024.1368481.
      
 
                                          
                                                          
  SirT7-mediated transcription of fascin in hyperglycemic glomerular endothelial cells contributes to EndMT in diabetic nephropathy.
  
    Wu M, Hao Y, Wu X, Zhu M, Chen X, Qi J
    
    
    Acta Biochim Biophys Sin (Shanghai). 2024; 56(4):586-596.
  
  
    PMID: 38449390
    
          PMC: 11090846.
    
          DOI: 10.3724/abbs.2024002.
      
 
                                          
                                                          
  Utilizing machine learning algorithms to identify biomarkers associated with diabetic nephropathy: A review.
  
    Dong B, Liu X, Yu S
    
    
    Medicine (Baltimore). 2024; 103(8):e37235.
  
  
    PMID: 38394492
    
          PMC: 11309603.
    
          DOI: 10.1097/MD.0000000000037235.